Citadel Advisors - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$596,770
-19.2%
42,596
-40.3%
0.00%
Q2 2023$738,783
-44.7%
71,380
-50.6%
0.00%
Q1 2023$1,334,958
+4.4%
144,476
+0.2%
0.00%
Q4 2022$1,278,495
+356.6%
144,137
+328.7%
0.00%
Q3 2022$280,000
-87.2%
33,621
-74.1%
0.00%
Q3 2021$2,180,000
+0.5%
129,598
-8.8%
0.00%
Q2 2021$2,170,000
+73.5%
142,049
+121.1%
0.00%
Q1 2021$1,251,000
+18.4%
64,245
+9.6%
0.00%
Q4 2020$1,057,000
+119.8%
58,626
+134.9%
0.00%
Q3 2020$481,000
-67.0%
24,959
-55.3%
0.00%
Q2 2020$1,457,000
-66.8%
55,793
-77.3%
0.00%
-100.0%
Q1 2020$4,388,000
-48.5%
245,978
-3.7%
0.00%
-25.0%
Q4 2019$8,523,000
+220.7%
255,383
+129.0%
0.00%
+300.0%
Q3 2019$2,658,000
-27.4%
111,511
+9.5%
0.00%
-50.0%
Q2 2019$3,659,000
-41.6%
101,805
-40.0%
0.00%
-33.3%
Q1 2019$6,267,000
-61.1%
169,649
-54.7%
0.00%
-66.7%
Q4 2018$16,119,000
-8.8%
374,332
+0.0%
0.01%
+12.5%
Q3 2018$17,676,000
+10.7%
374,234
+16.6%
0.01%0.0%
Q2 2018$15,974,000
+295.1%
321,034
+294.6%
0.01%
+300.0%
Q1 2018$4,043,00081,3580.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q3 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders